The novel therapy of this peptide represents a significant breakthrough in the care of diabetes mellitus type 2. Distinct from existing drugs, tirzepatide targets dual pathways – GLP-1 and GIP – resulting in https://tirzepatidepeptide062109.tinyblogging.com/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment-86312041